Interestingly, increased levels of KRT-9 have been found in the CSF from patients with Alzheimer’s disease, multiple sclerosis, and neuromyelitis optica compared to controls, and it has been proposed that this may be due to leakiness of the blood-brain barrier [38]. Here, KRT9 is linked to early-onset autosomal dominant Alzheimer disease.